A. Giannopoulos et al., Pharmacokinetics of intravenously administered pefloxacin in the prostate;perspectives for its application in surgical prophylaxis, INT J ANT A, 17(3), 2001, pp. 221-224
In an attempt to define whether intravenously administered pefloxacin might
be appropriate for surgical prophylaxis in prostatectomy. 50 patients unde
rgoing transvesical prostatectomy for benign prostate hyperplasia were give
n a single intravenous dose of 800 mg, surgery was then performed after 2.
4, 6, 8 or 10 h. Concentrations of perfloxacin were determined in serum and
in both the centre and periphery of the prostate adenoma using a microbiol
ogical plate assay. Elevated concentrations of pefloxacin were found in the
adenoma from 2 h onwards. The central and peripheral concentrations were s
imilar and had a mean value of 4.39 mug/g of tissue. These concentrations w
ere similar to those achieved in serum. Although concentrations of pefloxac
in were not determined separately in the intercellular, interstitial or exc
reted fluid, the tissue levels found were well above the MICs of perfloxaci
n for the bacteria commonly causing acute and chronic prostatitis. These da
ta suggest the intravenous administration of pefloxacin to be a satisfactor
y alternative for the surgical prophylaxis before prostatectomy as well as
in the therapy of acute prostatitis. (C) 2001 Elsevier Science B.V. and Int
ernational Society of Chemotherapy All rights reserved.